Exhalon
Developer of real-time breath analysis methods for volatile organic compound (VOC) biomarker discovery and clinical applications. Offers end-to-end services from clinical trial planning to assay development and validation, combining real-time gas analytics with AI-driven data analysis. Originated from hospital and academic research during the COVID-19 pandemic, with a validated rapid breath diagnostic method and an international patent.
Industries
Nr. of Employees
small (1-50)
Exhalon
12 avenue des Près, 78180 Montigny-le-Bretonneux, France
Products
Real-time Breath Analysis Technology
A technology that analyzes volatile organic compounds in exhaled breath to assess health status and diagnose respiratory diseases.
Biomarker Discovery Services
Services that identify and validate breath-based biomarkers for disease diagnosis and therapy response prediction.
Clinical Trial Planning and Support
Planning and support services for clinical trials involving breath analysis technologies and biomarker validation.
Diagnostics Applications
Non-invasive diagnostic solutions using breath analysis to detect diseases such as COVID-19.
Patient Monitoring Services
Continuous monitoring of patients' breath profiles to track health status and detect changes in real-time.
Prognostic Tools for Respiratory Diseases
Tools that predict disease progression and exacerbations in respiratory conditions using breath analysis.
Real-time Breath Analysis Technology
A technology that analyzes volatile organic compounds in exhaled breath to assess health status and diagnose respiratory diseases.
Biomarker Discovery Services
Services that identify and validate breath-based biomarkers for disease diagnosis and therapy response prediction.
Clinical Trial Planning and Support
Planning and support services for clinical trials involving breath analysis technologies and biomarker validation.
Diagnostics Applications
Non-invasive diagnostic solutions using breath analysis to detect diseases such as COVID-19.
Patient Monitoring Services
Continuous monitoring of patients' breath profiles to track health status and detect changes in real-time.
Prognostic Tools for Respiratory Diseases
Tools that predict disease progression and exacerbations in respiratory conditions using breath analysis.
Services
Design and planning of clinical studies for breath biomarker discovery and validation (end-to-end support).
Identification of diagnostic, prognostic, and therapy-response VOC biomarkers from exhaled breath using real-time analytics and AI.
Development and validation of analytical assays and methods to detect breath VOC biomarkers and support clinical deployment.
Design and planning of clinical studies for breath biomarker discovery and validation (end-to-end support).
Identification of diagnostic, prognostic, and therapy-response VOC biomarkers from exhaled breath using real-time analytics and AI.
Development and validation of analytical assays and methods to detect breath VOC biomarkers and support clinical deployment.
Expertise Areas
- Breath biomarker discovery
- Volatolomics / metabolomics
- Clinical trial management for biomarker validation
- Assay development and analytical validation
Key Technologies
- Real-time gas analytics for VOCs
- AI / machine learning for biosignature analysis
- Volatolomics (VOC profiling)
- Point-of-care VOC sensors
News & Updates
Chief Medical Officer and Co-founder appointed to lead metabolomics and breath analysis efforts for sepsis research at IHU PROMETHEUS.
Co-author published results on real-time breath analysis as a diagnostic tool for COVID-19 in ERJ Open Research.
Awarded an international patent in 2022 for a rapid, under-one-minute breath diagnostic method developed during the COVID-19 pandemic.
Organization spun off from hospital and university research teams in 2024 to commercialize real-time breath analysis services.
Chief Medical Officer and Co-founder appointed to lead metabolomics and breath analysis efforts for sepsis research at IHU PROMETHEUS.
Co-author published results on real-time breath analysis as a diagnostic tool for COVID-19 in ERJ Open Research.
Awarded an international patent in 2022 for a rapid, under-one-minute breath diagnostic method developed during the COVID-19 pandemic.
Organization spun off from hospital and university research teams in 2024 to commercialize real-time breath analysis services.